Items
Funding to evaluate AI technology for timely and equitable dementia diagnosis
ABATED Study Funding Announcement
Date added: Monday, May 9, 2022
AINOSTICS granted FDA Breakthrough Device Designation
AINOSTICS has been awarded Breakthrough Device Designation by the US Food and Drug Administration (FDA) to the product, BR[AI]N.
Date added: Thursday, September 8, 2022